medRxiv Preprints

{
  "doi": "10.64898/2026.07.27.26359036",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.27.26359036v1",
  "title": "Germline NF2 variant position constrains somatic second hits and determines clinical severity in Neurofibromatosis Type 2-related schwannomatosis",
  "source": "medrxiv",
  "authors": "Ravindra, N.; Asuzu, D. T.; Celano, E.; Kumar, S.; Chopra, A.; Mandal, D.; Mullaney, D.; Bhatt, D.; Laws, M. T.; Hayes, C.; Kunnath, I.; Sisay, B.; Elkahloun, A.; Asthagiri, A. R.; Lehky, T.; Zalewski, C.; Heiss, J. D.; Kim, H. N.; Chittiboina, P.",
  "version": "1",
  "abstract": "PurposeNeurofibromatosis type 2-related schwannomatosis (NF2-SWN) is an autosomal dominant tumor syndrome with complete penetrance and variable expressivity. Underlying patterns of disease burden and severity are largely unexplained. MethodsWe comprehensively phenotyped 168 NF2-SWN patients over a mean duration of 4.5 years. We used a custom sequencing panel of NF2 and schwannomatosis genes to identify germline (n=166) and somatic variants in tumors (n=37). An optimized composite severity (CSS) score based on clinical and radiological data was created to analyze the effect of genetic variants on phenotype. ResultsWe found significant variable expressivity not explainable by demographic variables. Germline variants included premature termination (42%), splice-site (18%), and large deletions (16%). The CSS successfully predicted worsening clinical function in patients. Unsupervised clustering of clinical data revealed distinct phenotypic clusters that corresponded to CSS. Mosaicism, however, was not associated with CSS or any other disease severity marker. CSS was significantly associated with germline variant location along the NF2 locus. Specifically, FERM-F1 and the -helical varia",
  "category": "oncology",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Prashant Chittiboina",
  "journal_published_doi": null,
  "corresponding_institution": "NINDS"
}

{
  "doi": "10.64898/2026.07.27.26359049",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.27.26359049v1",
  "title": "Forty-seven percent of pregnancies have stigmatizing language in their clinical notes in an electronic health record cohort",
  "source": "medrxiv",
  "authors": "Simha, N.; Takasuka, H.; Chen, L.-C.; Khan, U.; Oskotsky, T. T.; Sirota, M.; Capra, J. A.; Chen, I. Y.",
  "version": "1",
  "abstract": "Stigmatizing language in medical documentation may reflect and perpetuate bias, but its prevalence in obstetrics has not been systematically quantified. We applied a keyword-guided BERT classifier to 640,345 obstetric notes from 26,178 pregnancies at an academic medical center. Stigmatizing language was detected in 47% of 26,178 pregnancies. Black pregnancies had significantly higher odds of stigmatizing language compared with Asian (aOR=1.5, p=3x10-8) or White (aOR=1.4, p=6x10-6). Indicated and spontaneous preterm births were also significantly associated with stigmatizing language compared to term (aORs=1.5, 1.2; p=7x10-12, 0.01). Pregnant individuals with only 12th-grade maternal education were more likely to experience stigma than those with college (aOR=1.5; p=4x10-14). These findings provide evidence of differences in clinical documentation across race, education levels, and clinical conditions. They also demonstrate how automated natural language processing can enable systematic monitoring of bias in healthcare language at scale.",
  "category": "obstetrics and gynecology",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Irene Y Chen",
  "journal_published_doi": null,
  "corresponding_institution": "Department of Computational Precision Health, UCSF and UC Berkeley, San Francisco and Berkeley, USA"
}

{
  "doi": "10.64898/2026.07.27.26358977",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.27.26358977v1",
  "title": "Patterns of Gabapentin Use in Patients With Cervical Spondylotic Myelopathy",
  "source": "medrxiv",
  "authors": "Warner, B. C.; Arkam, F.; Yakdan, S.; Hammo, A.; Ray, W. Z.; Wilcox, A.; Foraker, R.; Lu, C.; Greenberg, J. K.",
  "version": "1",
  "abstract": "Cervical spondylotic myelopathy (CSM) is the most common cause of nontraumatic spinal cord dysfunction in adults and is an increasingly important source of disability as populations age. Gabapentin is widely prescribed for neuropathic pain and may therefore be used for symptoms related to known or undiagnosed CSM. However, there is sparse evidence related specifically to gabapentin's use for CSM-related pain. We investigate gabapentin use and trends over time in patients with CSM compared to matched controls. We observed that gabapentin prescriptions were higher in CSM patients compared to controls across two multi-hospital datasets. These results highlight the need for further research into pharmacologic treatment for chronic pain in CSM.",
  "category": "neurology",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Jacob K Greenberg",
  "journal_published_doi": null,
  "corresponding_institution": "Washington University in St. Louis"
}

{
  "doi": "10.64898/2026.07.27.26359039",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.27.26359039v1",
  "title": "Multimodal Sleep Physiology Reconstructs Cerebrospinal Fluid Dynamics: A Candidate Digital Biomarker from Noninvasive Sensing",
  "source": "medrxiv",
  "authors": "Banta, A. R.; Phillips, R. A.; D'Ambrosio, R.; Karmonik, C.; Golanov, E.; Regnier-Golanov, A.; Shaib, F.; Britz, G. W.; Aazhang, B.",
  "version": "1",
  "abstract": "Cerebrospinal fluid (CSF) dynamics are clinically important but can presently be measured only with expensive, non-portable imaging or invasive monitoring, precluding scalable assessment. We investigated whether CSF flow in the cerebral aqueduct can be reconstructed from noninvasive physiology recorded during sleep. In 22 healthy adults, with independent validation in 14 additional adults, regularized linear and ensemble regressors predicted the cardiac-cycle CSF flow waveform from electrocardiography, photoplethysmography (PPG), respiration, and electroencephalography acquired during overnight polysomnography, using 7-Tesla phase-contrast MRI as ground truth. Waveforms were reconstructed with high fidelity and generalized to the validation cohort, and deriving physiological metrics from the reconstructed waveform estimated peak velocity more accurately than predicting it directly. A minimal, wearable-oriented PPG feature set retained performance. These results support the feasibility of a noninvasive, potentially wearable digital biomarker of CSF dynamics and motivate evaluation in neurological disease populations.",
  "category": "neurology",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Anton Reza Banta",
  "journal_published_doi": null,
  "corresponding_institution": "Houston Methodist Academic Institute"
}

{
  "doi": "10.64898/2026.07.27.26359019",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.27.26359019v1",
  "title": "Phase One Development of a Patient-Reported Outcome Measure for Low Anterior Resection Syndrome",
  "source": "medrxiv",
  "authors": "Farrow, E.; Coxon-Meggy, A.; Knight, L.; Bissett, I.; Bordeianou, L.; Boutros, M.; Burch, J.; Christensen, P.; Corrigan, N.; Croft, J.; Demian, M.; Dhadlie, S.; Emmertsen, K. J.; Gordon, K.; Sarah Faris-Sabboobeh, S.; Fearnhead, N.; Flavio FioreJr, J.; Keane, C.; Knowles, C.; Lloydwin, C.; Marinello, F.; Meggy, A.; Mohan, H.; Ng, K.-S.; Oliveira, C. L. P.; Oliveira, L.; Quyn, A.; Rose, A.; Stocken, D.; Warwick, A.; White, J.; Cornish, J.",
  "version": "1",
  "abstract": "Background The Low Anterior Resection Syndrome (LARS) score is an internationally validated instrument for identifying bowel dysfunction following anterior resection for rectal cancer. Although widely used, it has been shown to have limited sensitivity for capturing the impact of LARS on daily-life and response to treatment. We have therefore developed a novel patient-reported outcome measure (PROM): the LARS Impact and Consequences Assessment Tool (LARS-ICAT). Methods Initial development of LARS-ICAT followed a five-stage process following established PROM development guidance. Stage one established the conceptual foundation through previously published Delphi consensus. Stage two involved item generation, followed by evaluation of content validity through patient focus groups (n=11) in stage three. Stage four comprised iterative expert review and refinement through clinical consensus with patient involvement. Stage five involved cognitive interviews with patients conducted across five rounds (n=23). Results Several items identified through the Delphi consensus were reworded as they included multiple concepts. A one-month recall period was selected, with six and four response opti",
  "category": "surgery",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Emily Farrow",
  "journal_published_doi": null,
  "corresponding_institution": "School of Medicine, Cardiff University, Cardiff, UK"
}

{
  "doi": "10.64898/2026.07.26.26358987",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.26.26358987v1",
  "title": "Stroke Knowledge and Its Determinants Among At-Risk Middle-Aged Adults in a Semi-Urban Nigerian Community",
  "source": "medrxiv",
  "authors": "Ubaka, C. M.; Ikeanyi, C. N.; Odeke, D. A.; Ugochukwu, E. J.; Eshiet, U.; Isah, A.",
  "version": "1",
  "abstract": "Background: Stroke is a leading cause of premature mortality and disability in sub-Saharan Africa. Effective prevention depends on timely recognition of stroke symptoms and awareness of its risk factors. This study assessed stroke knowledge and its independent predictors among at-risk middle-aged adults in a semi-urban Nigerian community. Methods: A community-based cross-sectional study was conducted among 316 adults aged 40-65 years using interviewer-administered questionnaires. Stroke knowledge was defined as adequate recognition of both stroke symptoms and risk factors. Pearson's chi-square test and multivariable binary logistic regression were used to identify independent predictors of combined stroke knowledge. Results: Although 296 (93.7%) respondents were aware of stroke, only 112 (35.4%) demonstrated good combined knowledge of stroke symptoms and risk factors. Sudden weakness of face, arm, or leg was the most correctly identified symptom (78{middle dot}6%), while sudden visual disturbance (34{middle dot}1%) and severe headache (37{middle dot}6%) were poorly recognized. Hypertension was the most identified risk factor (87{middle dot}6%), but atrial fibrillation (32{middle do",
  "category": "public and global health",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Chukwuemeka  Michael Ubaka",
  "journal_published_doi": null,
  "corresponding_institution": "University of Nigeria Faculty of Pharmaceutical Sciences"
}

{
  "doi": "10.64898/2026.07.27.26359031",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.27.26359031v1",
  "title": "Normative EEG Effective Connectivity as a Neural Marker of Autism Spectrum Disorder",
  "source": "medrxiv",
  "authors": "Amato, L. G.; Fattorini, F.; Vergani, A. A.; Pagani, M.; Meneghetti, N.; Mazzoni, A.; Fabbrizzi, M.",
  "version": "1",
  "abstract": "Autism spectrum disorder (ASD) is one of the most common neurodevelopmental disorders. The absence of a clear aetiology strengthens the need to identify quantitative biomarkers capable of diagnosing the condition and assessing the severity of symptoms. We implemented a normative modelling framework based on EEG effective connectivity (EC), leveraging recordings collected in three centers, in typical development (TD) and ASD participants with age spanning from 5 to 19 years. Deviations from the normative evolution were tested as ASD biomarkers, compared with standard EC metrics. Normative EC metrics supported accurate classification of ASD vs TD participants (0.82 AUC), reaching 0.95 AUC when combined with behavioral subscales, significantly outperforming a classification based on behavioral data alone. In ASD participants, selected metrics in the Temporo-Parietal-Frontal network predicted social responsiveness scale (SRS) values with high significance (SRS Total R^2=0.42, p=0.0005). These results suggest that normative EC values constitute robust and generalizable ASD biomarkers.",
  "category": "psychiatry and clinical psychology",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Lorenzo Gaetano Amato",
  "journal_published_doi": null,
  "corresponding_institution": "Scuola Superiore Sant'Anna"
}

{
  "doi": "10.64898/2026.06.22.26356176",
  "url": "https://www.medrxiv.org/content/10.64898/2026.06.22.26356176v2",
  "title": "TSPO PET binding in vivo reflects increased phagocytic microglia at post mortem in people with frontotemporal dementia",
  "source": "medrxiv",
  "authors": "Vontobel, D. S.; Lai, K. O.; Bacioglu, M.; Nolan, G.; Maddison, D. C.; Adamski, A.; Goddard, J.; Shapiro, N. L.; Crook, H.; Fryer, T.; Hong, Y.; Wijesinghe, S.; Aigbirhio, F.; Avezov, E.; Allinson, K. S. J.; Quaegebeur, A.; O'Brien, J. T.; Rowe, J. B.; Spillantini, M. G.; Malpetti, M.",
  "version": "2",
  "abstract": "Brain inflammation is a key feature of frontotemporal dementia (FTD). TSPO PET is widely used as an in vivo proxy for neuroinflammation, but whether the elevated signal reflects microglial, astrocytic, or vascular pathology is controversial. We paired ante mortem [11C]PK11195 TSPO PET with post mortem neuropathology in 10 individuals with FTD (5 FTLD-tau, 5 FTLD-TDP) and 5 controls, combining CD68 immunohistochemistry across 17 regions, multiplex immunofluorescence pairing TSPO with microglial/macrophagic (IBA1, CD68), astrocytic (GFAP) and endothelial (CD31) markers, and three-dimensional single-cell reconstruction. CD68 burden was elevated in FTD, concentrated in white matter, and correlated with regional TSPO PET binding across pathologies ({beta} = 8.40, P < 0.001). Only the CD68-TSPO co-localised fraction tracked the PET signal, with no TSPO upregulation per-cell. The elevated TSPO PET signal in FTD likely reflects an increased burden of lysosome-enriched CD68+ microglia, supporting TSPO PET as a microglial-burden biomarker in both FTLD-tau and FTLD-TDP.",
  "category": "pathology",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Maura Malpetti",
  "journal_published_doi": null,
  "corresponding_institution": "1 Department of Clinical Neurosciences, University of Cambridge 2 UK Dementia Research Institute, University of Cambridge 4 Cambridge University Hospitals NHS T"
}

{
  "doi": "10.64898/2026.07.27.26359009",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.27.26359009v1",
  "title": "Histological triage of early-stage mycosis fungoides using a weakly supervised deep learning-based model: a multicentre, external validation, and clinical utility study",
  "source": "medrxiv",
  "authors": "Doeleman, T.; Brussee, S.; Valkema, P.; Kempf, W.; Vermeer, M.; Kers, J.; Wynaendts, L.; Kerckhoffs, K.; de Jonge, M.; Nguyen, A.; Peters, E.; Wobser, M.; Rauert-Wunderlich, H.; Rosenwald, A.; Stadler, R.; Jansen, P.; Battistella, M.; Roccuzzo, G.; Quaglino, P.; Schrader, A.",
  "version": "1",
  "abstract": "Background Histological diagnosis of early-stage mycosis fungoides (MF) is hindered by profound overlap with benign inflammatory dermatoses (BIDs), leading to diagnostic delays and extensive ancillary testing. We developed MIMIC (Multiple Instance-learning for Identification of Mycosis fungoides In Cutaneous biopsies), a weakly supervised deep learning model designed as a triage tool at initial H&E whole slide image (WSI) review to distinguish classic patch and plaque stage MF from BIDs. We externally validated the model and evaluated its clinical utility. Methods In this retrospective multicentre study, we trained a base model using weakly supervised attention based multiple instance learning on 3,339 WSIs from two Dutch centres. Crucially, all MF training labels were derived from a deeply phenotyped national cohort featuring strict multidisciplinary expert panel consensus diagnoses (the clinical gold standard). Transportability was evaluated on 371 WSIs from four independent European centres. A blinded reader study on 171 WSIs compared morphology only performance of MIMIC with 11 (dermato-)pathologists. We then retrained an updated model on all retrospective multicentre data and ",
  "category": "pathology",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Thom Doeleman",
  "journal_published_doi": null,
  "corresponding_institution": "Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands"
}

{
  "doi": "10.1101/2025.11.23.25340799",
  "url": "https://www.medrxiv.org/content/10.1101/2025.11.23.25340799v4",
  "title": "Tryptophan metabolites are associated with gut-brain alterations in functional dyspepsia",
  "source": "medrxiv",
  "authors": "Ceulemans, M.; Wauters, L.; Weltens, N.; Vandermeulen, G.; de Loor, H.; Evenepoel, P.; Tito Tadeo, R. Y.; Vich Vila, A.; Derrien, M.; Dalile, B.; Tack, J.; Verbeke, K.; Raes, J.; Van Oudenhove, L.; Vanuytsel, T.",
  "version": "4",
  "abstract": "IntroductionDisturbances in the microbiota-gut-brain axis are thought to contribute to the pathophysiology of disorders of gut-brain interaction, including functional dyspepsia (FD), although comprehensive human data remain scarce. We aimed to study the relationships among microbiota-produced metabolites including tryptophan metabolites and short-chain fatty acids (SCFA), and functional brain connectivity in FD, in relation to symptomatology. MethodsIn 46 patients with Rome IV-diagnosed FD and 30 healthy controls (HC), targeted metabolomics using chromatography and mass spectrometry was conducted to quantify metabolites in blood, urine, and stool. Associations with gut microbiota and symptomatology were tested using fecal quantitative microbiota profiling and validated symptom questionnaires. Resting-state functional magnetic resonance imaging in 27 patients and 36 HC enabled analysis of functional connectivity in selected brain networks. ResultsPatients with FD exhibited distinct profiles of tryptophan metabolites and SCFA with higher urinary indole-3-acetate (IAA, P=0.018), lower serum kynurenine (P=0.030) and lower plasma propionate (P=0.0055) concentrations. FD-specific metabol",
  "category": "gastroenterology",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Tim Vanuytsel",
  "journal_published_doi": null,
  "corresponding_institution": "Katholieke Universiteit Leuven"
}